| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2081836 | Drug Discovery Today: Disease Mechanisms | 2008 | 5 Pages |
Abstract
MicroRNAs (miRNAs) are endogenous small ribonucleotides and they orchestrate development, growth, function and stress response of probably all cells by regulating target messenger RNA translation. Modulation of miRNA expression in vivo has revealed an important role for the control of heart function, particularly cardiac growth and conductance. Development and use of miRNA antagonists to target miRNAs in vivo may translate into novel therapeutic strategies for heart disease in the future.
Section editor:Christian Weber – Institute for Molecular Cardiovascular Research (IMCAR), Sprecher, Aachen University, Germany
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Thomas Thum, Johann Bauersachs,